Serum dipeptidyl peptidase-IV: A better screening test for early detection of mucopolysaccharidosis?

被引:7
|
作者
Kurt, Ismail [1 ]
Sertoglu, Erdim [2 ]
Okur, Ilyas [3 ]
Tapan, Serkan [1 ]
Uyanik, Metin [1 ]
Kayadibi, Huseyin [4 ]
Ezgu, Fatih Suheyl [3 ]
Aydin, Halil Ibrahim [5 ]
Hasanoglu, Alev [3 ]
机构
[1] Gulhane Mil Med Acad, Dept Med Biochem, Ankara, Turkey
[2] Ankara Mevki Mil Hosp, Biochem Lab, Ankara, Turkey
[3] Gazi Univ, Fac Med, Dept Pediat Metab & Nutr, Ankara, Turkey
[4] Adana Mil Hosp, Dept Med Biochem, Adana, Turkey
[5] Gulhane Mil Med Acad, Dept Pediat, Ankara, Turkey
关键词
Mucopolysaccharidoses; Urinary GAG/Creatinine ratio; Serum DPP-IV enzyme activity; LYSOSOMAL STORAGE DISORDERS; ADENOSINE-DEAMINASE; DIMETHYLMETHYLENE BLUE; PLASMA CHITOTRIOSIDASE; URINE SAMPLES; DIAGNOSIS; GLYCOSAMINOGLYCANS; PROTEINS; DISEASES; CD26;
D O I
10.1016/j.cca.2014.02.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We aimed to investigate the diagnostic utility of serum DPP-IV enzyme activity, urinary GAG/Cre ratio, chitotriosidase activity, total adenosine deaminase (ADA) and ADA-1 isoenzyme activity in the diagnosis of MPS. 31 MPS patients which were previously diagnosed by clinical and enzymatic analysis and 31 healthy controls matched with age and gender were included in this study. Serum DPP-IV enzyme activity, urinary GAG/Cre ratio, total ADA and ADA-1 isoenzyme activity were significantly higher in patients than in controls (p < 0.001, p < 0.001, p = 0.038 and p = 0.006, respectively). There were significant correlations between serum DPP-IV enzyme activity and urinary GAG/Cre ratios, ADA-1 activity, ADA-1/total ADA (r = 0.498, p < 0.001; r = 0.348, p = 0.006; r = 0.270, p = 0.034, respectively). Area under ROC curve for DPP-IV enzyme activity was 0.988, p < 0.001 and for urinary GAG/Cre ratio was 0.986, p < 0.001. DPP-IV enzyme activity and urinary GAG/Cre ratio were the most significant parameters according to the univariate logistic regression analysis (p = 0.001 and p < 0.001, respectively). The measurement of serum DPP-IV enzyme activity can be used complementary to the urinary GAG/Cre ratio for first-line MPS screening, since it is more less prone to age and hydration related interferences. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 50 条
  • [41] AN ECORI POLYMORPHISM WITHIN THE DIPEPTIDYL PEPTIDASE-IV (DPPIV) GENE
    ABBOTT, CA
    KOOREY, D
    MCCAUGHAN, GW
    HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1507 - 1507
  • [42] Neuroprotective effects of inhibitors of dipeptidyl peptidase-IV in vitro and in vivo
    Wu, YQ
    Limburg, DC
    Wilkinson, DE
    Jackson, P
    Steiner, JP
    Hamilton, GS
    Belyakov, SA
    DIPEPTIDYL AMINOPEPTIDASES IN HEALTH AND DISEASE, 2003, 524 : 351 - 355
  • [43] CIRCADIAN CHANGES OF DIPEPTIDYL PEPTIDASE-IV ACTIVITY IN MOUSE KIDNEY
    LOJDA, Z
    BALSCHUN, D
    HISTOCHEMICAL JOURNAL, 1986, 18 (11-12): : 665 - 665
  • [44] Drug eruption caused by sitagliptin, a dipeptidyl peptidase-IV inhibitor
    Tanaka, Keiko
    Ogawa, Youichi
    Shimada, Shinji
    JOURNAL OF DERMATOLOGY, 2012, 39 (08): : 726 - 728
  • [45] DIPEPTIDYL PEPTIDASE-IV ACTIVITY IN STIMULATED LYMPHOCYTES-T
    HENDRIKS, D
    DEMEESTER, I
    UMIEL, T
    VANHOOF, G
    SCHARPE, S
    YARON, A
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1988, 16 (03) : 365 - 366
  • [46] PURIFICATION AND PROPERTIES OF DIPEPTIDYL PEPTIDASE-IV FROM HUMAN URINE
    CHIKUMA, T
    HAMA, T
    NAGATSU, T
    KUMEGAWA, M
    KATO, T
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (04): : 325 - 330
  • [47] A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma
    Zhang, Jing
    Qian, Xing-Kai
    Song, Pei-Fang
    Li, Xiao-Dong
    Wang, An-Qi
    Huo, Hong
    Yao, Jing-Chun
    Zhang, Gui-Min
    Zou, Li-Wei
    ANALYTICAL METHODS, 2021, 13 (24) : 2671 - 2678
  • [48] DIPEPTIDYL PEPTIDASE-IV IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    STANCIKOVA, M
    LOJDA, Z
    LUKAC, J
    RUZICKOVA, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1992, 10 (04) : 381 - 385
  • [49] Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening
    Cheon, HG
    Lee, CM
    Kim, BT
    Hwang, KJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) : 2661 - 2664
  • [50] Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors
    Edmondson, Scott D.
    Mastracchio, Anthony
    Cox, Jason M.
    Eiermann, George J.
    He, Huaibing
    Lyons, Kathryn A.
    Patel, Reshma A.
    Patel, Sangita B.
    Petrov, Aleksandr
    Scapin, Giovanna
    Wu, Joseph K.
    Xu, Shiyao
    Zhu, Bing
    Thornberry, Nancy A.
    Roy, Ranabir Sinha
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4097 - 4101